Skip to main content
Year archive

ALGORAE PHARMACEUTICALS LIMITED — 2010 filings

All 63 regulatory filings released by ALGORAE PHARMACEUTICALS LIMITED (1AI) in 2010, sourced directly from the official regulator.

63 Filings
2010 Period
2010 filings (63)
Filing Released Lang
LCT executes $5.75m funding agreement 3 pages 249.1KB
Capital/Financing Update
2010-12-30 English
LCT Negotiating Funding 2 pages 32.9KB
Capital/Financing Update
2010-12-22 English
Securities Trading Policy 7 pages 231.4KB
Governance Information
2010-12-22 English
Initial Director`s Interest Notice 2 pages 28.2KB
Director's Dealing
2010-12-21 English
Appointment of Alternate Director 1 page ?Kb
Board/Management Information
2010-12-20 English
LCT Approved to Further Expand DIABECELL NZ Trial 2 pages ?Kb
Capital/Financing Update
2010-12-19 English
LCT`s DiabeCell Registered for Sale and Use in Russia 2 pages ?Kb
Regulatory Filings
2010-12-09 English
Final Director`s Interest Notice - Simon O`Loughlin 2 pages ?Kb
Director's Dealing
2010-11-22 English
Final Director`s Interest Notice - David McAuliffe 2 pages ?Kb
Director's Dealing
2010-11-22 English
Final Director`s Interest Notice - David Brookes 3 pages ?Kb
Director's Dealing
2010-11-22 English
Trading Halt 2 pages ?Kb
Board/Management Information
2010-11-17 English
CEO`S Presentation to the 2010 AGM 15 pages ?Kb
AGM Information
2010-11-17 English
Results of the 2010 Annual General Meeting 4 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2010-11-17 English
LCT Appoints New Chairman 2 pages ?Kb
AGM Information
2010-11-17 English
Lifting of Trading Halt 1 page ?Kb
Board/Management Information
2010-11-17 English
Change of Director`s Interest Notice 3 pages ?Kb
Director's Dealing
2010-11-14 English
Promising Preclinical Results with NTCELL in Parkinsons 3 pages ?Kb
Regulatory Filings
2010-11-09 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-11-01 English
Appendix 4C - quarterly 7 pages ?Kb
Interim / Quarterly Report
2010-10-28 English
LCT reports sustained improvement from DIABECELL NZ Trial 3 pages ?Kb
Regulatory Filings
2010-10-26 English
Annual Report to shareholders 43 pages ?Kb
Annual Report
2010-10-17 English
Notice of Annual General Meeting/Proxy Form 10 pages ?Kb
AGM Information
2010-10-17 English
LCT BIO Investor Forum Presentation 25 pages ?Kb
Investor Presentation
2010-10-06 English
LCT Managing Director to speak at American Investor Forum 2 pages ?Kb
Regulatory Filings
2010-10-04 English
Final Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-09-23 English
LCT Restructures Executive Team for Commercial Focus 2 pages ?Kb
Board/Management Information
2010-09-22 English
Appendix 4E - Preliminary Final Report 6 pages ?Kb
Annual Report
2010-08-26 English
Financial Report for the year ended 30 June 2010 61 pages ?Kb
Annual Report
2010-08-26 English
LCT Presentation to Australian Investors 24 pages ?Kb
Investor Presentation
2010-08-25 English
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-08-08 English
Remuneration of Managing Director 3 pages ?Kb
Remuneration Information
2010-08-05 English
LCT receives approval to expand DIABECELL NZ Trial 3 pages ?Kb
Regulatory Filings
2010-08-03 English
Appointment of Managing Director 3 pages ?Kb
Board/Management Information
2010-08-01 English
Appendix 4C - quarterly 7 pages ?Kb
Interim / Quarterly Report
2010-07-29 English
LCT Presentation to Australian Investors 22 pages ?Kb
Investor Presentation
2010-07-19 English
Section 708A (5) (e) Cleansing Statement 1 page ?Kb
Capital/Financing Update
2010-07-14 English
LCT reports consistent benefit in DIABECELL NZ Trial 3 pages ?Kb
Regulatory Filings
2010-07-12 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-07-12 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-07-06 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-07-01 English
Presentation to American Diabetes Association 42 pages ?Kb
Regulatory Filings
2010-06-27 English
LCT Presentation at American Diabetes Association 3 pages ?Kb
Investor Presentation
2010-06-27 English
LCT Options underwritten 2 pages ?Kb
Capital/Financing Update
2010-06-21 English
Appendix 3B 7 pages ?Kb
Capital/Financing Update
2010-06-10 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change
2010-05-27 English
Living Cell Technologies - Corporate Presentation 23 pages ?Kb
Investor Presentation
2010-05-19 English
Appendix 4C 7 pages ?Kb
Interim / Quarterly Report
2010-04-28 English
LCT receives grant from Juvenile Diabetes Research Foundn 3 pages ?Kb
Regulatory Filings
2010-04-26 English
Investor Presentation 30 pages ?Kb
Investor Presentation
2010-04-07 English
Report from LCTs Russian Phase I / IIa Diabetes Trial 5 pages ?Kb
Regulatory Filings
2010-04-06 English
LCT Phase II Diabetes Trial Success - Approval to Progress 3 pages ?Kb
Regulatory Filings
2010-03-29 English
Response to ASX Price Query 3 pages ?Kb
Regulatory Filings
2010-03-16 English
Russia registers LCT encapsulation delivery device 2 pages ?Kb
Regulatory Filings
2010-03-09 English
Half Yearly Report and Accounts 26 pages ?Kb
Interim / Quarterly Report
2010-02-24 English
LCT Awarded NZ$4.04 Million New Zealand Government Grant 2 pages ?Kb
Capital/Financing Update
2010-02-11 English
LCT Receives 10% of US Based Wound Healing Company 2 pages ?Kb
Regulatory Filings
2010-02-08 English
Appendix 4C - quarterly 7 pages ?Kb
Interim / Quarterly Report
2010-01-28 English
LCT alerted to issue of fake share certificates 2 pages ?Kb
Regulatory Filings
2010-01-26 English
LCT Granted European Patent for NTCELL 3 pages ?Kb
Regulatory Filings
2010-01-19 English
Change of Director`s Interest Notice 3 pages ?Kb
Director's Dealing
2010-01-03 English
Change of Director`s Interest Notice 4 pages ?Kb
Director's Dealing
2010-01-03 English
Change of Director`s Interest Notice 3 pages ?Kb
Director's Dealing
2010-01-03 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing
2010-01-03 English